Clinical trial
A Randomized, Multicenter, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of WC3011 in Postmenopausal Women With Dyspareunia
NCT01845649 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multicenter, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of WC3011 in Postmenopausal Women With Dyspareunia
- Lead sponsor
- Warner Chilcott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 12, 2013
- Completion date
- November 20, 2013
- Enrollment
- 550 (actual)
- Sites
- 57
Conditions
As the registry lists them; a condition with its own page is linked.
vulvovaginal atrophy